197 related articles for article (PubMed ID: 12699864)
1. Topiramate effectiveness in Prader-Willi syndrome.
Smathers SA; Wilson JG; Nigro MA
Pediatr Neurol; 2003 Feb; 28(2):130-3. PubMed ID: 12699864
[TBL] [Abstract][Full Text] [Related]
2. Effects of topiramate in adults with Prader-Willi syndrome.
Shapira NA; Lessig MC; Lewis MH; Goodman WK; Driscoll DJ
Am J Ment Retard; 2004 Jul; 109(4):301-9. PubMed ID: 15176917
[TBL] [Abstract][Full Text] [Related]
3. Topiramate attenuates self-injurious behaviour in Prader-Willi Syndrome.
Shapira NA; Lessig MC; Murphy TK; Driscoll DJ; Goodman WK
Int J Neuropsychopharmacol; 2002 Jun; 5(2):141-5. PubMed ID: 12135538
[TBL] [Abstract][Full Text] [Related]
4. Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature.
Bonnot O; Cohen D; Thuilleaux D; Consoli A; Cabal S; Tauber M
Eur J Pediatr; 2016 Jan; 175(1):9-18. PubMed ID: 26584571
[TBL] [Abstract][Full Text] [Related]
5. Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled study.
Consoli A; Çabal Berthoumieu S; Raffin M; Thuilleaux D; Poitou C; Coupaye M; Pinto G; Lebbah S; Zahr N; Tauber M; Cohen D; Bonnot O
Transl Psychiatry; 2019 Nov; 9(1):274. PubMed ID: 31685813
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutical approach of obesity in Prader-Willi Syndrome].
Carvalho DF; Cercato C; Almeida MQ; Mancini MC; Halpern A
Arq Bras Endocrinol Metabol; 2007 Aug; 51(6):913-9. PubMed ID: 17934657
[TBL] [Abstract][Full Text] [Related]
7. The use of fluoxetine in an adolescent with Prader-Willi syndrome.
Dech B; Budow L
J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):298-302. PubMed ID: 2016235
[TBL] [Abstract][Full Text] [Related]
8. Effects of mazindol in two patients with Prader-Willi syndrome.
Itoh M; Koeda T; Ohno K; Takeshita K
Pediatr Neurol; 1995 Nov; 13(4):349-51. PubMed ID: 8771175
[TBL] [Abstract][Full Text] [Related]
9. Behavioral characteristics of Prader-Willi syndrome in Korea: comparison with children with mental retardation and normal controls.
Kim JW; Yoo HJ; Cho SC; Hong KE; Kim BN
J Child Neurol; 2005 Feb; 20(2):134-8. PubMed ID: 15794180
[TBL] [Abstract][Full Text] [Related]
10. Emergence of compulsive behavior and tantrums in children with Prader-Willi syndrome.
Dimitropoulos A; Feurer ID; Butler MG; Thompson T
Am J Ment Retard; 2001 Jan; 106(1):39-51. PubMed ID: 11246711
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of naltrexone for treating pathologic skin picking behavior in an adolescent with Prader-Willi syndrome.
Banga A; Connor DF
J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):396-8. PubMed ID: 23083028
[No Abstract] [Full Text] [Related]
12. Physiological adaptation after a 12-week physical activity program for patients with Prader-Willi syndrome: two case reports.
Amaro AS; Teixeira MC; de Mesquita ML; Rodrigues GM; Rubin DA; Carreiro LR
J Med Case Rep; 2016 Jun; 10(1):181. PubMed ID: 27339289
[TBL] [Abstract][Full Text] [Related]
13. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
14. Add-on topiramate reduces weight in overweight patients with affective disorders: a clinical case series.
Kirov G; Tredget J
BMC Psychiatry; 2005 Apr; 5():19. PubMed ID: 15817130
[TBL] [Abstract][Full Text] [Related]
15. Naltrexone and fluoxetine in Prader-Willi syndrome.
Benjamin E; Buot-Smith T
J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):870-3. PubMed ID: 8340312
[TBL] [Abstract][Full Text] [Related]
16. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome.
Bittel DC; Kibiryeva N; Butler MG
Pediatrics; 2006 Oct; 118(4):e1276-83. PubMed ID: 16982806
[TBL] [Abstract][Full Text] [Related]
17. Intensive management of obesity in people with Prader-Willi syndrome.
Nolan BJ; Proietto J; Sumithran P
Endocrine; 2022 Jun; 77(1):57-62. PubMed ID: 35524875
[TBL] [Abstract][Full Text] [Related]
18. Failure of fluoxetine to modify the skin-picking behaviour of Prader-Willi syndrome.
Schepis C; Failla P; Siragusa M; Palazzo R; Romano C
Australas J Dermatol; 1998 Feb; 39(1):57-8. PubMed ID: 9529694
[No Abstract] [Full Text] [Related]
19. Characteristics of abnormal food-intake patterns in children with Prader-Willi syndrome and study of effects of naloxone.
Zipf WB; Berntson GG
Am J Clin Nutr; 1987 Aug; 46(2):277-81. PubMed ID: 3618531
[TBL] [Abstract][Full Text] [Related]
20. Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.
Griggs JL; Sinnayah P; Mathai ML
Neurosci Biobehav Rev; 2015 Dec; 59():155-72. PubMed ID: 26475993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
